NewEdge Advisors’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$74.5K Sell
2,229
-1,654
-43% -$61.4K ﹤0.01% 2836
2025
Q4
$135K Buy
3,883
+1,266
+48% +$46.7K ﹤0.01% 2684
2025
Q3
$97.8K Sell
2,617
-10,077
-79% -$348K ﹤0.01% 2609
2025
Q2
$412K Buy
12,694
+1,338
+12% +$38.2K ﹤0.01% 1815
2025
Q1
$306K Buy
+11,356
New +$333K ﹤0.01% 1880
2023
Q1
Sell
-416
Closed -$9.08K 3665
2022
Q4
$9.08K Buy
+416
New +$10.3K ﹤0.01% 2404
2019
Q4
Sell
-7,776
Closed -$251K 831
2019
Q3
$251K Sell
7,776
-21,134
-73% -$722K 0.01% 687
2019
Q2
$991K Buy
28,910
+8,999
+45% +$303K 0.06% 281
2019
Q1
$667K Buy
+19,911
New +$627K 0.04% 337

Other funds holding FFTY

NewEdge Advisors's FFTY Position: Q1 2026 in Review

NewEdge Advisors reduced its CapForce IBD 50 ETF (FFTY) stake by 43% in Q1 2026, selling an estimated $61.4K and leaving 2,229 shares worth $74.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2836.

NewEdge Advisors first reported a position in FFTY in Q1 2019 and has held it in 9 quarters since. The position peaked at $991K in Q2 2019. 39 funds tracked by Wall St. Rank hold FFTY as of Q1 2026.

  • NewEdge Advisors held 2,229 shares of CapForce IBD 50 ETF worth $74.5K as of Q1 2026.
  • NewEdge Advisors sold 1,654 CapForce IBD 50 ETF shares in Q1 2026, an estimated $61.4K.
  • CapForce IBD 50 ETF made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #2836 holding.
  • NewEdge Advisors first reported a position in CapForce IBD 50 ETF in Q1 2019 and has held it in 9 quarters since.
  • NewEdge Advisors's CapForce IBD 50 ETF position peaked at $991K in Q2 2019.
  • 39 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.